• Editorial|Open Access

    Myocardial ischemia in women: problems and challenges

    Tamar Vakhtangadze, Nino Gakhokidze
    Vessel Plus 2017;1:43-8. | doi:10.20517/2574-1209.2016.05
    Published on: 27 Jun 2017  | Viewed:3095  | Downloaded:148
    +HTML| PDF
  • Review|Open Access

    Blood purification in intensive care patients with multiple organ dysfunction syndrome and sepsis after cardiac surgery

    Michael Yaroustovsky, Marina Abramyan, Ekaterina Komardina, Helen Nazarova
    Extracorporeal blood purification is becoming increasingly important in intensive therapy for multiple organ dysfunction syndrome (MODS) and sepsis, considering all of their pathophysiological aspects. The results of treatment, particularly in children, considering their anatomical and... Read more
    Vessel Plus 2017;1:49-60. | doi:10.20517/2574-1209.2017.11
    Published on: 27 Jun 2017  | Viewed:3310  | Downloaded:202
    +HTML| PDF
  • Original Article|Open Access

    Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes

    Lesya Bobronnikova
    Aim: To determine the impact of galectin-3 levels on the progression of metabolic disorders and structural-functional changes in the myocardium and blood vessels in patients with concomitant systemic arterial hypertension (AH) and type 2 diabetes mellitus (type 2 DM). Methods: Ninety-five... Read more
    Vessel Plus 2017;1:61-7. | doi:10.20517/2574-1209.2016.10
    Published on: 27 Jun 2017  | Viewed:1055  | Downloaded:81
    +HTML| PDF
  • Original Article|Open Access

    Initial experience with bioresorbable vascular scaffolds for percutaneous revascularisation in patients with acute coronary syndrome

    Alberto Cordero, Ramón López-Palop, Pilar Carrillo, Araceli Frutos, Clara Gunturiz, Maria García-Carrilero, Vicente Bertomeu-Martinez
    Aim: Bioresorbable vascular scaffolds (BVS) have recently been introduced to minimise the long-term complications of metallic stents in acute coronary syndrome (ACS), but their benefits have not been well analysed. Methods: The authors studied all ACS patients treated with any kind of stent at a... Read more
    Vessel Plus 2017;1:68-76. | doi:10.20517/2574-1209.2017.02
    Published on: 27 Jun 2017  | Viewed:1313  | Downloaded:86
    +HTML| PDF
  • Original Article|Open Access

    The effect of postoperative malperfusion after surgical treatment of type A acute aortic dissection on early and mid-term survival

    Paolo Nardi, Carlo Olevano, Carlo Bassano, Emanuele Bovio, Lorenzo Cecchetti, Stefano Forlani, Giovanni Ruvolo
    Aim: To evaluate whether postoperative malperfusion (PM) affected in-hospital and long-term survival in acute type A aortic dissection (AAAD) surgical patients and to identify risk factors for PM. Methods: Patients who underwent AAAD surgery at a single institution between January 2005 and March... Read more
    Vessel Plus 2017;1:77-83. | doi:10.20517/2574-1209.2017.07
    Published on: 27 Jun 2017  | Viewed:1985  | Downloaded:127
    +HTML| PDF
  • Short Communication|Open Access

    Heart and vascular remodeling in essential hypertension and type 2 diabetes is dependent on genetic polymorphisms

    Anna Shalimova
    Aim: To study heart and vascular remodeling in essential hypertension (EH) and concomitant type 2 diabetes mellitus (DM2) with respect to genetic polymorphism of the angiotensin II receptor type 1 (AGTR1) gene and peroxisome proliferator-activated receptor-γ2 (PPARγ2). Methods: Biochemical blood... Read more
    Vessel Plus 2017;1:84-90. | doi:10.20517/2574-1209.2016.08
    Published on: 27 Jun 2017  | Viewed:2912  | Downloaded:111
    +HTML| PDF
  • Case Report|Open Access

    LDL apheresis or PCSK9 inhibition? Sometimes we have to combine them

    Mariann Harangi, Lilla Juhász, Bíborka Nádró, József Balla, György Paragh
    This study presents the case of a female patient with severe heterozygous familial hypercholesterolemia. Despite the combined maximum dose oral treatment with rosuvastatin and ezetimibe, we found markedly elevated lipid parameters. Therefore, we indicated monthly selective low density lipoprotein... Read more
    Vessel Plus 2017;1:91-5. | doi:10.20517/2574-1209.2017.08
    Published on: 27 Jun 2017  | Viewed:2392  | Downloaded:148
    +HTML| PDF
Vessel Plus ISSN 2574-1209 (Online)
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.